Compagnie Lombard Odier SCmA’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $16M | Buy |
|
|||||
2025
Q1 | $8.88M | Sell |
|
|||||
2024
Q4 | $10.5M | Sell |
|
|||||
2024
Q3 | $10.1M | Sell |
|
|||||
2024
Q2 | $17.7M | Buy |
|
|||||
2024
Q1 | $21.2M | Buy |
|
|||||
2023
Q4 | $15.7M | Buy |
|
|||||
2023
Q3 | $9.7M | Buy |
|
|||||
2023
Q2 | $4.25M | Buy |
|
|||||
2023
Q1 | $1.75M | Buy |
|
|||||
2022
Q4 | $991K | Buy |
|
|||||
2022
Q3 | $216K | Hold |
|
|||||
2022
Q2 | $199K | Sell |
|
|||||
2022
Q1 | $420K | Buy |
|
|||||
2021
Q4 | $146K | Sell |
|
|||||
2021
Q3 | $285K | Buy |
|
|||||
2021
Q2 | $116K | Hold |
|
|||||
2021
Q1 | $97K | Hold |
|
|||||
2020
Q4 | $100K | Hold |
|
|||||
2020
Q3 | $111K | Sell |
|
|||||
2020
Q2 | $142K | Sell |
|
|||||
2020
Q1 | $135K | Hold |
|
|||||
2019
Q4 | $109K | Hold |
|
|||||
2019
Q3 | $75K | Sell |
|
|||||
2019
Q2 | $105K | Buy |
|
|||||
2019
Q1 | $60K | Sell |
|
|||||
2018
Q4 | $842K | Sell |
|
|||||
2018
Q3 | $65.5M | Sell |
|
|||||
2018
Q2 | $57.6M | Sell |
|
|||||
2018
Q1 | $56.7M | Sell |
|
|||||
2017
Q4 | $102M | Buy |
|
|||||
2017
Q3 | $41.4M | Buy |
|
|||||
2017
Q2 | $57.8M | Buy |
|
|||||
2017
Q1 | $64.7M | Sell |
|
|||||
2016
Q4 | $51.8M | Buy |
|
|||||
2016
Q3 | $42.1M | Buy |
|